GB9914743D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9914743D0
GB9914743D0 GBGB9914743.1A GB9914743A GB9914743D0 GB 9914743 D0 GB9914743 D0 GB 9914743D0 GB 9914743 A GB9914743 A GB 9914743A GB 9914743 D0 GB9914743 D0 GB 9914743D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914743.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Priority to GBGB9914743.1A priority Critical patent/GB9914743D0/en
Publication of GB9914743D0 publication Critical patent/GB9914743D0/en
Priority to MXPA01013421A priority patent/MXPA01013421A/en
Priority to JP2001505896A priority patent/JP2003503343A/en
Priority to CA002376886A priority patent/CA2376886A1/en
Priority to EP00947848A priority patent/EP1218008A2/en
Priority to AU61502/00A priority patent/AU6150200A/en
Priority to PCT/EP2000/005543 priority patent/WO2001000186A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
GBGB9914743.1A 1999-06-24 1999-06-24 Therapeutic agents Ceased GB9914743D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9914743.1A GB9914743D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
MXPA01013421A MXPA01013421A (en) 1999-06-24 2000-06-16 Therapeutic agents.
JP2001505896A JP2003503343A (en) 1999-06-24 2000-06-16 Therapeutic agent
CA002376886A CA2376886A1 (en) 1999-06-24 2000-06-16 Therapeutic agents
EP00947848A EP1218008A2 (en) 1999-06-24 2000-06-16 New use of 1,2,4-triazolo[1,5-a]pyrimidines
AU61502/00A AU6150200A (en) 1999-06-24 2000-06-16 Therapeutic agents
PCT/EP2000/005543 WO2001000186A2 (en) 1999-06-24 2000-06-16 New use of 1,2,4-triazolo'1,5-a! pyrimidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914743.1A GB9914743D0 (en) 1999-06-24 1999-06-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9914743D0 true GB9914743D0 (en) 1999-08-25

Family

ID=10855954

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914743.1A Ceased GB9914743D0 (en) 1999-06-24 1999-06-24 Therapeutic agents

Country Status (7)

Country Link
EP (1) EP1218008A2 (en)
JP (1) JP2003503343A (en)
AU (1) AU6150200A (en)
CA (1) CA2376886A1 (en)
GB (1) GB9914743D0 (en)
MX (1) MXPA01013421A (en)
WO (1) WO2001000186A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2358716B1 (en) 2008-11-12 2016-01-06 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (fabp)
US8759357B2 (en) 2009-10-08 2014-06-24 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (FABP)
KR101775682B1 (en) * 2015-11-30 2017-09-06 주식회사 대웅 Methods for Preparing Botulinum Toxin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
GB9906124D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Therapeutic agent
GB9906130D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Compounds for use in therapy
GB9906126D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Pharmaceutical formulations

Also Published As

Publication number Publication date
AU6150200A (en) 2001-01-31
MXPA01013421A (en) 2002-07-30
WO2001000186A2 (en) 2001-01-04
JP2003503343A (en) 2003-01-28
EP1218008A2 (en) 2002-07-03
WO2001000186A3 (en) 2002-05-10
CA2376886A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
HK1200316A1 (en) Therapeutic microfoams
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
GB9921351D0 (en) Therapeutic agents
GB9801234D0 (en) Therapeutic agents
PL339848A1 (en) Therapeutic agent against hypephosphataemia
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9929569D0 (en) Therapeutic agents
GB9911802D0 (en) Therapeutic combination
GB9911803D0 (en) Therapeutic combination
GB9914744D0 (en) Therapeutic agents
GB9911804D0 (en) Therapeutic combination
GB9801202D0 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
GB9914745D0 (en) Therapeutic agents
GB9914742D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
GB9914743D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)